Australia Next-generation Sequencing Services Market Size, Share, By Service Types (Human Genome, Single Cell, Microbial Genome-based, Gene Regulation Services, Small RNA, Animal & Plant, and Other Gene Regulation-based Services), By End Use (Universities & Other Research Entities, Hospitals & Clinics, Pharma & Biotech Entities, and Others), Australia Next-generation Sequencing Services Market Insights, Industry Trend, Forecasts to 2035

Australia Next-generation Sequencing Services Market Insights Forecasts to 2035

• Australia Next-generation Sequencing Services Market Size 2024: USD 240.5 Mn
• Australia Next-generation Sequencing Services Market Size 2035:  USD 2694.1 Mn
• Australia Next-generation Sequencing Services Market CAGR 2024: 24.56%
• Australia Next-generation Sequencing Services Market Segments: Service Type and End Use

The market of the next-generation sequencing services in Australia represents the industry that provides high-throughput genomic sequencing services through the use of advanced NGS technologies. These services conducted rapid and low-cost analysis of DNA and RNA, and the like, for genomic research, clinical diagnostics, personalized medicine, cancer profiling, rare disease identification, monitoring of infectious diseases, and drug development. Through NGS services, the researchers, hospitals, and biotech companies in Australia were able to produce large-scale genomic data with high precision, rapidity, and scalability. The market for next-generation sequencing services in Australia is currently expanding at a very fast pace, and the main reason for this is the growing demand for high-throughput genomic analysis in precision medicine, cancer profiling, and genetic research, among other applications.

The Australian NGS services market has been made possible through government initiatives such as the Genomics Health Futures Mission (AUD 500.1 million), MRFF Genomics Health Futures Grants (AUD 48.8 million), and funding to educational institutions such as UNSW (AUD 4.92 million). In addition to these initiatives, programs like Genomics Australia (AUD 30 million) and project grants have been allocated to promote genomic research, infrastructure, and clinical NGS adoption throughout the country.

Among the newest changes in the NGS services market of Australia are the installation of NOVA Seq X Plus by Australian Genome Research Facility (AGRF), the presentation of Roche's Sequencing by Expansion (SBX) technology at AGTA 2025, and the introduction of low-cost portable NGS devices. All these advancements are helping to improve sequencing speed, accuracy, and coverage of different fields like research, oncology, rare diseases, and clinical applications throughout the country.

Market Dynamics of the Australia Next-generation Sequencing Services Market:

The Australia next-generation sequencing services market is driven by the growing trend for precision medicine, coupled with the growing incidence of cancers and genetic disorders. Added momentum into this growth pathway will come from increased investment through government funding (Genomics Health Futures Mission) to support research and development (R&D) advancements in technology (i.e., high-throughput sequencing technology), as well as the emergence of new and improved low-cost genomics sequencing technology (i.e., Next Generation Sequencing Platforms). In addition, the increased number of sequencing services being outsourced by hospitals, research facilities, and pharmaceutical companies will continue to drive this market and increase the national adoption level of NGS services.

The Australia next-generation sequencing services market is restrained by the high initial and operational costs associated with equipment, limited availability of skilled workforce, data protection and regulatory issues related to bioinformatics, as well as limited access to infrastructure in rural or out-of-the-way areas; lastly, the complexity of bioinformatics analysis creates barriers to wide-scale adoption of NGS services in Australia.

Precision medicine, oncology profiling, and rare disease diagnostics are the driving forces behind the Australian NGS services market, which is poised to capture the most significant part of the future healthcare pie. The major innovations will be in the fields of ultra-high-throughput sequencing, long-read technologies, single-cell sequencing, and AI-assisted bioinformatics integration, all aimed at improving accuracy and speeding up the process. There will also be a growth in the market segment that covers pathogen surveillance, real-world data platforms, and decentralized sequencing solutions for the healthcare settings of less populated areas and remote regions.

Market Segmentation

The Australia Next-generation Sequencing Services Market share is classified into service type and end use.

By Service Type:

The Australia next-generation sequencing services market is divided by service type into human genome, single cell, microbial genome-based, gene regulation services, small RNA, animal & plant, and other gene regulation-based services. Among these, the human genome segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Human genome sequencing is the most popular and valuable NGS service in Australia because it offers crucial insights for clinical decision-making, research, and therapeutic development. This dominance is fueled by the growing demand for precision medicine, genetic disorder diagnosis, cancer profiling, and personalized treatment.

By End Use:

The Australia next-generation sequencing services market is divided by end use into universities & other research entities, hospitals & clinics, pharma & biotech entities, and others. Among these, the universities & other research entities segment accounted for the largest share in 2024 and is projected to grow at a significant CAGR during the forecast period. Strong government funding for genomics research, numerous academic partnerships, extensive population and disease studies, and a high demand for outsourced sequencing services, many research institutions favor external NGS providers over maintaining in-house sequencing infrastructure, are the main factors driving this dominance.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the Australia next-generation sequencing services market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Top Key Companies in Australia Next-generation Sequencing Services Market:

• Australian Genome Research Facility (AGRF)
• Micromon Genomics
• Ramaciotti Centre for Genomics
• Macrogen Australia
• Garvan Institute of Medical Research
• Sonic Healthcare
• Decode Science
• CSIRO Genomics Collaboration Units
• State/Tertiary Hospital Genomics Labs
• University Core Sequencing Facilities
• Others

Recent Developments in Australia Next-generation Sequencing Services Market:

In July 2025, Genomics Australia heralded the announcement of Genomics Australia as a national body that would facilitate and integrate genomics (NGS inclusive) into the health sector across Australia, thereby reporting under the Department of Health.

In March 2025, Parse Biosciences successfully reached out with its single-cell sequencing to the staff of the South Australian Genomics Centre (SAGC), thereby making great access to flexible single-cell sequencing technologies in Australia.

In June 2024, the signing of a contract for the Australian Genome Research Facility (AGRF) to work closely with Dovetail Genomics, thereby taking the genomic world by storm through advanced 3D genome technologies like Link Prep and Omni-C sequencing tools.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Australia, regional, and country levels from 2020 to 2035. Spherical insights has segmented the Australia next-generation sequencing services market based on the below-mentioned segments:

Australia Next-generation Sequencing Services Market, By Service Type

• Human Genome
• Single Cell
• Microbial Genome-based
• Gene Regulation Services
• Small RNA
• Animal & Plant
• Other Gene Regulation-based Services

Australia Next-generation Sequencing Services Market, By End Use

• Universities & Other Research Entities
• Hospitals & Clinics
• Pharma & Biotech Entities
• Others